HH&L Acquisition Co.
| General Information | |
| Business: | We intend to focus on healthcare or healthcare-related companies in Asian markets with a focus on the Greater China market, or global healthcare or healthcare-related companies with a meaningful growth thesis in the Greater China or Asian markets, which can benefit from the expertise and capabilities of our management team in order to create long-term shareholder value. (Note: HH&L Acquisition priced its IPO on Feb. 5, 2021, on upsized terms: 36 million units, up from 30 million in the prospectus, at $10 each to raise $360 million.) |
| Industry: | BLANK CHECKS |
| Employees: | 0 |
| Founded: | 2020 |
| Contact Information | |
| Address | Suite 3508, One Exchange Square 8 Connaught Place Central, Hong Kong |
| Phone Number | (852) 3752 2870 |
| Web Address | |
| View Prospectus: | HH&L Acquisition Co. |
| Financial Information | |
| Market Cap | $375.0mil |
| Revenues | $0 mil (last 12 months) |
| Net Income | $0 mil (last 12 months) |
| IPO Profile | |
| Symbol | HHLA.U |
| Exchange | NYSE |
| Shares (millions): | 36.0 |
| Price range | $10.00 - $10.00 |
| Est. $ Volume | $360.0 mil |
| Manager / Joint Managers | Goldman Sachs/ Credit Suisse |
| CO-Managers | - |
| Expected To Trade: | 2/5/2021 |
| Status: | Priced |
| Quiet Period Expiration Date: | Available only to Subscribers |
| Lock-Up Period Expiration Date: | Available only to Subscribers |
| SCOOP Rating | Available only to Subscribers |
| Rating Change | Available only to Subscribers |